title: A new era in medical therapy for retinal degenerative disease?
authors.affiliation: Retinal Degenerations and Ophthalmic Genetics Service, Hamilton Eye Institute, Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN 38163, USA. Electronic address: aiannacc@uthsc.edu.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Iannaccone
authors.affiliation: Institute of Ophthalmology and Visual Science, Rutgers-New Jersey Medical School, Rutgers University, Newark, NJ, USA.
authors.forename: Marco A
authors.initials: MA
authors.lastname: Zarbin
mesh_terms: D001766:Blindness / Q000188:drug therapy*; D004224:Diterpenes; D006801:Humans; D057130:Leber Congenital Amaurosis / Q000188:drug therapy*; D000084562:Retinyl Esters; D014801:Vitamin A / Q000008:administration & dosage / Q000031:analogs & derivatives*
chemical_list: D004224:Diterpenes; D000084562:Retinyl Esters; D014801:Vitamin A; C009166:retinol acetate